← All companies
ILLUMINA, INC.
ILMN - CIK 0001110803
Market cap$24.84 B
Rank#539
SEC filings3,713
ILLUMINA, INC. trades as ILMN and has a market capitalization of $24.84 B, making it the #539 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $4.34B, down 0.7% from the prior year and net income of $850.00M. This page tracks ILLUMINA, INC. through 3,713 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$4.34BFY 2025
Net income (latest FY)$850.00MFY 2025
Operating cash flow (latest FY)$1.08BFY 2025
Total assets (latest FY)$6.64BFY 2025
Gross margin66.1%latest FY
Net margin19.6%latest FY
Financial performance
Over the last 8 fiscal years ILLUMINA, INC.'s revenue grew from $2.40B to $4.34B, a compound annual growth rate of 7.7%. Net profit margin expanded from 19.3% to 19.6% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $24.84 B
- Share price (derived)market cap / shares outstanding
- $164.16
- P/E ratio (trailing FY)
- 29.2
- EPS (diluted)FY 2025
- $5.45
- Shares outstandingas of 2026-04-24
- 0.15B
- Total equityas of 2026-03-29
- $2.68B
- Return on equity
- 31.8%
- Stock buybacksFY 2025
- $742.00M
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
Recent press releases
- David P King Elected To Illuminas Board Of Directors2026-05-21
Illumina, Inc. - David P. King elected to Illumina's Board of Directors
- Illumina, Inc. - Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact2026-05-19
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact
- Illumina, Inc. - Illumina Reports Financial Results for First Quarter of Fiscal Year 20262026-04-30
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026
- Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research2026-04-16
Illumina, Inc. - DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
- Illumina And The Center For Data Driven Discovery In Biomedicine Bring Genomic Data And Scalable Software To The Fight Against Pediatric Cancer And Rare Disease2026-04-14
Illumina, Inc. - Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
Similar companies
The largest companies sharing ILLUMINA, INC.'s SEC industry classification (laboratory analytical instruments).
Frequently asked questions
What is ILLUMINA, INC.'s market cap?
ILLUMINA, INC. (ILMN) has a market capitalization of $24.84 B as of 2026-06-11, ranking #539 among US-listed companies.
How much revenue does ILLUMINA, INC. make?
ILLUMINA, INC. reported revenue of $4.34B for fiscal year 2025, a decrease of 0.7% year over year.
Is ILLUMINA, INC. profitable?
Yes. ILLUMINA, INC. reported net income of $850.00M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.